Mark N. Wegman

All filings by Mark N. Wegman on record concern Biospecifics Technologies Corp. The record holds 16 filings, for trades running from 20 June 2018 to 2 December 2020.

Every open-market trade on record is a sale: 7 sales worth €1.5M. Other entries cover 3 share grants and 1 option exercise.

On 2 December 2020 came the latest disclosure, a transaction in Biospecifics Technologies Corp. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.